-+ 0.00%
-+ 0.00%
-+ 0.00%

Cube Labs forms Serescentia unit to commercialize health and longevity products

PUBT·07/24/2026 17:22:22
Listen to the news
Cube Labs forms Serescentia unit to commercialize health and longevity products
  • Cube Labs created Serescentia, a wholly owned unit, to add a dedicated commercial and distribution platform alongside its venture-building operations.
  • Serescentia was capitalized at EUR 10,000, targeting health, wellness, healthy aging products, longevity science, nutraceuticals.
  • Plans include scouting European healthcare SMEs, with three early targets identified at 0.5-3.5 million in revenue for potential acquisitions.
  • Growth funding is expected to combine proceeds from Cube Labs’ ongoing capital increase with bank debt.
  • Cube Labs’ Hiperforming Research AI tools are set to be integrated into Serescentia to support marketing, sales, customer service, personalization.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cube Labs S.p.A. published the original content used to generate this news brief on July 24, 2026, and is solely responsible for the information contained therein.